183 related articles for article (PubMed ID: 18946087)
41. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
Liao WH; Wang CT
Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
[TBL] [Abstract][Full Text] [Related]
42. Single-amino acid mutation 66SR in Gag-matrix enhances viral single-cycle infectivity of R5-tropic HIV-1rmt.
Doi N; Sakai Y; Miyazaki Y; Adachi A; Nomaguchi M
J Med Invest; 2015; 62(3-4):228-32. PubMed ID: 26399353
[TBL] [Abstract][Full Text] [Related]
43. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.
Müller B; Daecke J; Fackler OT; Dittmar MT; Zentgraf H; Kräusslich HG
J Virol; 2004 Oct; 78(19):10803-13. PubMed ID: 15367647
[TBL] [Abstract][Full Text] [Related]
44. A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41.
Davis MR; Jiang J; Zhou J; Freed EO; Aiken C
J Virol; 2006 Mar; 80(5):2405-17. PubMed ID: 16474147
[TBL] [Abstract][Full Text] [Related]
45. Evidence that productive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment.
Joshi A; Ablan SD; Soheilian F; Nagashima K; Freed EO
J Virol; 2009 Jun; 83(11):5375-87. PubMed ID: 19297499
[TBL] [Abstract][Full Text] [Related]
46. Roles of the interactions between Env and Gag proteins in the HIV-1 replication cycle.
Murakami T
Microbiol Immunol; 2008 May; 52(5):287-95. PubMed ID: 18557900
[TBL] [Abstract][Full Text] [Related]
47. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L
Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884
[TBL] [Abstract][Full Text] [Related]
48. Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus.
Murray JL; Mavrakis M; McDonald NJ; Yilla M; Sheng J; Bellini WJ; Zhao L; Le Doux JM; Shaw MW; Luo CC; Lippincott-Schwartz J; Sanchez A; Rubin DH; Hodge TW
J Virol; 2005 Sep; 79(18):11742-51. PubMed ID: 16140752
[TBL] [Abstract][Full Text] [Related]
49. SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV.
Gonzalez-Enriquez GV; Escoto-Delgadillo M; Vazquez-Valls E; Torres-Mendoza BM
J Immunol Res; 2017; 2017():1548905. PubMed ID: 29359168
[TBL] [Abstract][Full Text] [Related]
50. HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release.
Chutiwitoonchai N; Siarot L; Takeda E; Shioda T; Ueda M; Aida Y
PLoS One; 2016; 11(9):e0163100. PubMed ID: 27648839
[TBL] [Abstract][Full Text] [Related]
51. Chimeric HIV-1 containing SIV matrix exhibit enhanced assembly in murine cells and replicate in a cell-type-dependent manner in human T cells.
Chen P; Hübner W; Riviere K; Liu YX; Chen BK
Virology; 2006 May; 349(1):1-12. PubMed ID: 16563454
[TBL] [Abstract][Full Text] [Related]
52. HTLV-1 Gag protein associates with CD82 tetraspanin microdomains at the plasma membrane.
Mazurov D; Heidecker G; Derse D
Virology; 2006 Mar; 346(1):194-204. PubMed ID: 16325219
[TBL] [Abstract][Full Text] [Related]
53. Protein methylation is required to maintain optimal HIV-1 infectivity.
Willemsen NM; Hitchen EM; Bodetti TJ; Apolloni A; Warrilow D; Piller SC; Harrich D
Retrovirology; 2006 Dec; 3():92. PubMed ID: 17169163
[TBL] [Abstract][Full Text] [Related]
54. Subcellular Localization of HIV-1
Becker JT; Sherer NM
J Virol; 2017 Mar; 91(6):. PubMed ID: 28053097
[TBL] [Abstract][Full Text] [Related]
55. Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1.
Gurer C; Berthoux L; Luban J
J Virol; 2005 Jan; 79(2):910-7. PubMed ID: 15613319
[TBL] [Abstract][Full Text] [Related]
56. Specific incorporation of cyclophilin A into HIV-1 virions.
Franke EK; Yuan HE; Luban J
Nature; 1994 Nov; 372(6504):359-62. PubMed ID: 7969494
[TBL] [Abstract][Full Text] [Related]
57. Opposing effects of a tyrosine-based sorting motif and a PDZ-binding motif regulate human T-lymphotropic virus type 1 envelope trafficking.
Ilinskaya A; Heidecker G; Derse D
J Virol; 2010 Jul; 84(14):6995-7004. PubMed ID: 20463077
[TBL] [Abstract][Full Text] [Related]
58. Rab11-FIP1C and Rab14 direct plasma membrane sorting and particle incorporation of the HIV-1 envelope glycoprotein complex.
Qi M; Williams JA; Chu H; Chen X; Wang JJ; Ding L; Akhirome E; Wen X; Lapierre LA; Goldenring JR; Spearman P
PLoS Pathog; 2013; 9(4):e1003278. PubMed ID: 23592992
[TBL] [Abstract][Full Text] [Related]
59. IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Compton AA; Bruel T; Porrot F; Mallet A; Sachse M; Euvrard M; Liang C; Casartelli N; Schwartz O
Cell Host Microbe; 2014 Dec; 16(6):736-47. PubMed ID: 25464829
[TBL] [Abstract][Full Text] [Related]
60. Encapsidation of Staufen-2 Enhances Infectivity of HIV-1.
Balakrishnan K; Jaguva Vasudevan AA; Mohareer K; Luedde T; Münk C; Banerjee S
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
